EyePod

Thomas Brunner, president & CEO, Glaucoma Research Foundation, San Francisco, CA, shares his thoughts on how living through a pandemic has influenced and altered his perspective on life — both personally and professionally — for the better. 

Oluwatosin U. Smith, MD, Glaucoma Associates of Texas, offers an update on optimization and surgical modifications of newer glaucoma surgeries in preop and postop settings.

Ophthalmology Times®' Sheryl Stevenson speaks with Marc Mathias, MD, a retinal specialist from Children’s Hospital Colorado, who offers insight on managing cases of inherited retinal dystrophies in pediatric patients, as well as an update on the rapidly changing treatment landscape, thanks to ongoing clinical trials in novel IRD and genetic therapies.

Peter J. Polack, MD, FACS, and Zora Harrison, COO at Ocala Eye in North Central Florida, share the protocols and technology their practice implemented throughout the pandemic that has enabled them to safely and efficiently treat their patients.

Mary Elizabeth Hartnett, MD, FACS, FARVO, a distinguished professor in Ophthalmology and Visual Sciences, University of Utah, as well as director of Pediatric Retina at the John A. Moran Eye Center, and Mark Breazzano, MD, a vitreous and retinal surgeon at the Wilmer Eye Institute, Johns Hopkins University, analyze two areas of AMD relevant to today's field: Dr. Hartnett highlights current researc...

Sahar Bedrood, MD, PhD, a glaucoma/cataract specialist at Acuity Eye Group (Pasadena, CA), and a clinical assistant professor at USC Roski Eye Institute, shares her clinical perspective on the multi-faceted, dynamic evolution of interventional glaucoma. 

John H. Merey, MD, possibly one of the last Holocaust survivors still in the practice of ophthalmology, shares his experience. 

Thomas Samuelson, MD, speaks on the outcomes of a three-year trial analyzing the iStent inject trabecular micro-bypass + phaco versus phaco alone in patients with POAG.

Ehsan Rahimy, MD, speaks on the highlights of a study he presented at this year's virtual AAO 2020 meeting that aimed to integrate an artificial intelligence screening system for managing diabetic retinopathy referrals in a primary care setting — with limited specialty support.

Anne L. Coleman, MD, PhD, president of the American Academy of Ophthalmology (AAO), offers a preview of what attendees can look forward to from the academy's 2020 virtual annual meeting — kicking off Nov. 13-15 —including: in-depth information and innovations, free entry to the 17th annual Orbital Gala, open access to all 8 subspecialty days, new innovations, a first-ever talent show, extended acc...

John J. Grande, CFP, and John S. Grande, CFP, of Grande Financial Services, discuss how having a solid financial plan in place can ease anxiety amid the ongoing coronavirus pandemic and ahead of a potential second wave, advice to ophthalmologists contemplating retirement, as well as the financial repercussions the economy may face heading into 2021.

Ranya Habash, MD, medical director, Technology Innovation, Bascom Palmer Eye Institute, University of Miami, speaks with Ophthalmology Times®' Sheryl Stevenson on the capabilities of telemedicine available to ophthalmologists, the impact of the pandemic in regards to FDA regulations and how it’s helped to pave the way forward / expand telemedicine, as well as why the future of telemedicine require...

S.K. Steven Houston III, MD, speaks with Ophthalmology Times®' Sheryl Stevenson on how his practice has put to use recent retina innovations and adapted to accommodate the ever-changing operating room spacing and set-up in the current COVID-19 environment.

Dilraj Grewal, MD, associate professor of ophthalmology at Duke Eye Center/ director of grading at the Duke Reading Center, speaks with Ophthalmology Times® ' David Hutton on his presentation "Evaluating the True 3-Year Recurrence Rate in Non-infectious Posterior Segment Uveitis Following an Injectable Fluocinolone Acetonide Insert (FAi)," during the virtual 2020 American Society of Retina Special...

Victor Gonzalez, MD, speaks with Ophthalmology Times® David Hutton on the highlights of his presentation regarding "Two-year outcomes from the PALADIN Phase 4 study: Anatomic/functional changes and reduced treatment frequency associated with 0.19 mg of fluocinolone acetonide implant (FAc) with persistent or recurrent diabetic macular edema," during the 2020 Association for Research in Vision and O...

Dee Stephenson, MD, ABO, speaks with Ophthalmology Times'® David Hutton on the highlights of her presentation " Early Clinical Assessment of Aberration Neutral One-Piece Monofocal Toric IOL with Enhanced Optic Recovery and Alignment ORA " during the 2020 ASCRS virtual meeting.

John Berdahl, MD, of Vance Thompson Vision, speaks with Ophthalmology Times'® David Hutton on the highlights of his presentation "Ocular Surface Disease Improvement in Eyes Implanted with Trabecular Meshwork Bypass Stents (iStent or iStent inject)," during the 2020 ASCR virtual meeting.

Soroosh Behshad, MD, MPH, of the Emory Eye Center, speaks with Ophthalmology Times '® David Hutton on the key takeaways from the presentation on, "Corneal crosslinking outcomes in children with progrssive keratoconus," during the 2020 ASCRS virtual meeting.

Julianne Matthews, MD, MPH, a resident at The Ohio State University, speaks with Ophthalmology Times' ® David Hutton on the key highlights from her presentation "How Long Does It Take for Bcva, Kmax, and Pachymetry to Return to Baseline after Corneal Collagen Crosslinking for Keratoconus?," during the 2020 ASCRS virtual meeting.

Alice Epitropoulos, MD, FACS, from The Cataract & Refractive Center of Ohio, speaks with Ophthalmology Times'® David Hutton on the key highlights from her presentation "Image quality or depth of field or both: Clinical outcomes from spherical aberration neutral monofocal toric IOL," during the 2020 ASCRS virtual meeting.